Poseida Therapeutics, Inc. (PSTX)

NASDAQ: PSTX · IEX Real-Time Price · USD
1.97
-0.02 (-1.01%)
May 25, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year2021202020192018
Revenue
31.24000
Gross Profit
31.24000
Selling, General & Admin
35.9223.0318.469.67
Research & Development
136.73103.5260.3930.88
Other Operating Expenses
006.681.43
Operating Expenses
172.65126.5585.5341.99
Operating Income
-141.41-126.55-85.53-41.99
Interest Expense / Income
3.363.513.551.8
Other Expense / Income
-19.8-0.28-2.560.82
Pretax Income
-124.97-129.78-86.53-44.61
Income Tax
000-0.2
Net Income
-124.97-129.78-86.53-44.4
Net Income Common
-124.97-129.78-86.53-44.4
Shares Outstanding (Basic)
62361312
Shares Outstanding (Diluted)
62361312
Shares Change
72.89%185.27%3.57%-
EPS (Basic)
-2.01-3.61-6.86-3.64
EPS (Diluted)
-2.01-3.61-6.86-3.64
Free Cash Flow Per Share
-1.69-3.62-5.52-3.23
Gross Margin
100.00%---
Operating Margin
-452.69%---
Profit Margin
-400.07%---
Free Cash Flow Margin
-336.64%---
Effective Tax Rate
0.00%0.00%0.00%0.45%
EBITDA
-117.06-123.68-81.78-42.12
EBITDA Margin
-374.75%---
EBIT
-121.62-126.27-82.97-42.81
EBIT Margin
-389.32%---
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).